John Burrill, PhD

John Burrill, PhD, is director of product management and market development, reproductive health, at Thermo Fisher Scientific. Burrill joined the company as director of portfolio and program management in March 2016 through Thermo’s acquisition of Affymetrix. At Affymetrix, he served in a variety of roles, the last being as senior director for software development, leading the team responsible for Affymetrix commercial software. Prior to joining Affymetrix, Burrill worked at Applied BioSystems and Incyte Genomics. Burrill is a graduate of the University of Chicago and holds a PhD in neuroscience from the University of Michigan.